HCA Healthcare: Will Upcoming Payer Negotiations Unlock Stronger Reimbursement Power Or Spark Fresh Pressure?

HCA Healthcare’s first quarter of 2026 performance reflected a dynamic operational environment marked by both transitory challenges and ongoing strategic initiatives. The company reported a 4.3% increase in revenue compared to the first quarter of the prior year, with adjusted EBITDA growing nearly 2%, and adjusted diluted earnings per share rising approximately 11%. Despite these improvements, volume trends were affected by an atypically mild respiratory season and severe winter storms that tempered expected seasonal volume gains. Respiratory-related admissions decreased by 42%, and emergency room visits by 32% year-over-year, while the storms particularly impacted Texas, Tennessee, North Carolina, and Virginia operations. These factors collectively reduced adjusted EBITDA by an estimated $180 million for the quarter. Counterbalancing these volume headwinds, HCA Healthcare realized greater-than-anticipated benefits from Medicaid supplemental payment programs, primarily due to approvals in Georgia and Texas and the expansion of Tennessee’s program.